Showing results (31-40 of 302) with videos related to
Sort By:
Pageof 31
Anti-Cancer Drugs|October 6, 2011
Erlotinib as maintenance therapy in patients with advanced non-small cell lung cancer: a pooled analysis of three randomized trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.BMC Cancer|July 6, 2016
TAS-102, the first "cardio-gentle" fluoropyrimidine in the colorectal cancer landscape?Fausto Petrelli, Sandro Barni, Paola Bertocchi, et al.Tumori|June 6, 2015
That tumor you're going to get tomorrow … maybe: making an informed decisionEnrico Aitini, Francesca Adami, Sandro Barni, et al.Breast Cancer (Tokyo, Japan)|February 12, 2011
A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancerFausto Petrelli, Mary Cabiddu, Cecilia Barbara, et al.Clinical Colorectal Cancer|July 20, 2016
TAS-102 (Lonsurf) for the Treatment of Metastatic Colorectal Cancer. A Concise ReviewAlberto Zaniboni, Paola Bertocchi, Sandro Barni, et al.Expert Opinion on Investigational Drugs|September 10, 2009
Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?Fausto Petrelli, Mary Cabiddu, Mara Ghilardi, et al.Giornale Italiano Di Cardiologia (2006)|June 11, 2013
[Monitoring of cardiac damage in cancer patients treated with cardiotoxic drugs]Luigi Tarantini, Pompilio Faggiano, Sandro Barni, et al.Clinical Lung Cancer|November 8, 2011
Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small-cell lung cancer: a meta-analysis of 13 randomized trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.Journal of Gastrointestinal Oncology|August 2, 2014
Gastric cancer: toward a cisplatin-free disease?Fausto Petrelli, Sandro Barni, Stefano Cascinu, et al.The Oncologist|August 25, 2017
Salvage Therapy in Advanced Adult Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis of Randomized TrialsAlessandro Comandone, Fausto Petrelli, Antonella Boglione, et al.Pageof 31